drugset / Trial / NCT01330927
Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH)
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to establish the dose response relationship of VA106483 and nocturnal urine volumes in a population of elderly male subjects with Benign Prostatic Hypertrophy (BPH) who are likely to present with nocturia.
Timeline
- Start
- 2011-03
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VA106483 | Small molecule | 0.5 mg | Oral |
| Subject | VA106483 | Small molecule | 1 mg | Oral |
| Subject | VA106483 | Small molecule | 2 mg | Oral |
| Subject | VA106483 | Small molecule | 4 mg | Oral |